3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Gemcitabine
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Vorinostat
×
30 days
×
Clear all
No trials found.